8. gopal antiarrhythmic pcol350_8502010

Upload: schmeichel001

Post on 04-Jun-2018

230 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    1/18

    PCOL350.6 /850.6Antiarrhythmics

    Venkat Gopal

    Tel: 374-9110; 373-3923

    [email protected]

    2010 1.1

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    2/18

    List of Antiarrhythmic Drugs1. Class I: Na+ Channel Blockers:

    Quinidine, Lidocaine, Flecainide, Encainide

    Block Conduction - Affects Phase 0 of AP.

    2. Class II: Non-selective - Blockers:

    (Metoprolol, Sotalol)SA Node Automaticity

    Conduction Velocity in AV Node.

    3. Class III: Amiodarone,Bretylium, SotalolProlongs Action Pot. Duration & QT Interval,

    4. Cass IV: CCBs: (Verapamil, Diltiazem)

    Slows Conduction Velocity in AV NodeSVT

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    3/18

    Objectives

    Following this event, the learner will be able to: Describe action potentials and the ion currents in various

    phases

    List the 4 (or 5) classes of antiarrhythmic action. Give 1-

    2 examples of drugs with each effect. Describe 2 mechanisms of tachyarrhythmia

    Identify torsades de pointes

    Describe the main outcome of the CAST trial

    Describe an approach to the treatment of AVRNT, AFib,VT.

    2010 1.1

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    4/18

    Clinical background

    Definition: any heart rhythm other than normal sinus

    Bradycardia: < 60 bpm

    Tachycardia: >100 bpm< 30: pacemaker (atropine while waiting)

    > 150 + unstable: DC cardioversion

    2010 1.1

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    5/18

    Basic Science Review

    2010 1.1

    Na

    K

    Ca

    NaK

    Ca

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    6/18

    Review EP: Phase 0 Conduction Velocity Phase 1,2, 3: QT Interval

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    7/18

    Complexity: the Na channel

    2010 1.1

    The h gate is voltage dependent (closes at +ve voltage)

    Calcium and potassium channels are also voltage

    dependent

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    8/18

    More (but quick) review

    2010 1.1

    Sinus + AV nodes different:

    Spont. depol (pacemaker)

    Slow phase O (cond. veloc)

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    9/18

    Vaughan-Williams (1970)

    Class 1a Na channel(K channel)

    cond. velocQT (refr)

    quinidinedisopyramide

    Class 1b Na channel

    (inactive only)

    cond. veloc*

    QT

    lidocaine

    mexiletine

    phenytoin

    Class 1c Na channel cond. veloc

    , QT

    flecainide

    propafenone

    Class 2 Ca channel

    (indirect thru BB)

    cond. veloc

    Sinus, AV node

    metoprolol

    Class 3 K channel QT sotalol*,

    amiodarone

    Class 4 Ca channel(direct)

    cond. velocSinus, AV node

    Verapamil

    diltiazem

    Class 5 ? Purine ag. AV node adenosine2010 1.1

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    10/18

    Types of arrhythmias

    Generation Pacemaker cells

    Too fast, (too slow)

    2010 1.1

    Condn (re-entry) Within or between

    chambers

    Class 2, 4

    pacemakerClass 1,2,3,4,

    SVT, Afib, AFlttr., VFlttr, VFib

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    11/18

    The proarrhythmic effect(CAST trial, New Engl J Med 1991; 324: 781-8)

    Encainide (n= 432), flecainide (323), placebo (743)

    Drug Placebo

    deaths 63 26(p

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    12/18

    A word on amiodarone

    2010 1.1

    synthesized 1961

    angina, later arrhythmias

    approved in Canada 1980, USA 1985

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    13/18

    More words on amiodarone

    Class 3, 2, 4 activity-no better antiarrhythmic

    Good for AFib, Aflutter, VT, VF

    Little proarrhythmic effect Weird PK: Vd=66L/kg; t = 25-100 d.

    i.v and oral loading doses (10 gr,1-3 weeks)

    Lots of AE (75% after 2 years; doserelated (Thyroid, lung, liver, eye, skin, etc!)

    2010 1.1

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    14/18

    Amiodarone AEGoldschager N et al.Arch Int Med 2000; 160: 1741

    Low Dose(

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    15/18

    Nutshel ls Class I antiarrhythmic drugs act primarily as sodium

    channel blockers and they have greater access or higheraffinity for cells in the activated or inactivated state than

    for cells in the resting state.

    Cells in an ischemic area spend a larger proportion of

    time in the activated and inactivated states than in the

    resting state. It follows that the sodium channel blockers

    will exert a greater effect in ischemic tissue than in

    normal tissue.

    By further depressing conduction in the areas with

    depressed conduction (e.g. ischemic area), sodium

    channel blockers often produce bidirectional block. By

    this means they abort re-entry mechanisms to

    overcome arrhythmias.

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    16/18

    Nutshel lsBeta- blockers are most effective in conditions associated with

    high sympathetic activity.

    Calcium channel blockers are the drugs of choice in

    supraventricular tachycardias. Note that Verapamiland

    diltiazem have a proportionally greater effect on cardiac tissuethan vascular tissue compared to nifedipine, and they are the

    drugs of choice. Nifedipine is not recommended because of the

    reflex tachycardia associated with this agent.

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    17/18

    Summary

    There are 4 (5?) classes of antiarrhythmic effect.

    Drugs may act by more than 1 mech. (sotalol=2+3)

    Proarrhythmic effects are common, esp. TdP

    TdP caused by prolonged QT (repolarizationphase)

    Amiodarone(acts - 2,3, 4 Class) is the nuclear

    weapon despite adverse effects on prolonged use.

    2010 1.1

  • 8/13/2019 8. Gopal Antiarrhythmic PCOL350_8502010

    18/18